Viewing Study NCT00223080



Ignite Creation Date: 2024-05-05 @ 12:03 PM
Last Modification Date: 2024-10-26 @ 9:19 AM
Study NCT ID: NCT00223080
Status: COMPLETED
Last Update Posted: 2019-04-24
First Post: 2005-09-13

Brief Title: HIV Vaccine Trial in Thai Adults
Sponsor: US Army Medical Research and Development Command
Organization: US Army Medical Research and Development Command

Study Overview

Official Title: A Phase III Trial of Aventis Pasteur Live Recombinant ALVAC-HIV vCP1521 Priming With VaxGen gp120 BE AIDSVAX BE Boosting in HIV-uninfected Thai Adults
Status: COMPLETED
Status Verified Date: 2019-04
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: The purpose of this study is to determine whether immunizations with an integrated combination of ALVAC-HIV vCP1521 boosted by AIDSVAX gp120 BE prevent HIV infection in healthy Thai volunteers
Detailed Description: A vaccine for the prevention of HIV infection remains an urgent need as part of the efforts to control the HIV pandemic In this phase III efficacy trial a prime-boost vaccine strategy is evaluated for prevention of infection and amelioration of disease course ALVAC-HIV vCP1521 from sanofi pasteur is given as the prime vaccine at months 0 1 3 and 6 AIDSVAX gp120 BE from VaxGen is given as the boost at months 3 and 6 This regimen will be given to 8000 adult Thai subjects while another 8000 will be given placebos in a double-blinded randomized manner Following the completion of each subjects immunization phase heshe will be followed for 3 years with clinic visits every 6 months with HIV testing pre- and post-test counseling Subjects who become HIV infected will be counseled referred to HIV treatment facilities for management according to national guidelines and offered enrollment in a protocol for extended follow-up

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None
Secondary IDs
Secondary ID Type Domain Link
HSRRB A-11048 OTHER USAMRMC HSRRB None